Gornitzky & Co

Ari Fried

Current View:

This content is provided by Chambers. Learn more about our methodology

Global

Ari Fried was co-lead partner advising Oppenheimer & Co, in its capacity as lead underwriter, on a follow-on offering by Intec Pharma valued at USD57.5 million. Interviewees regard him as a "very, very good lawyer" who is "easy to work with, knowledgeable, smart, responsive and commercial."